Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value

• Yvonne Chekaluk ,

  Contributed equally to this work with: Yvonne Chekaluk, Chin-Lee Wu

  Affiliation Division of Translational Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Chin-Lee Wu ,

  Contributed equally to this work with: Yvonne Chekaluk, Chin-Lee Wu

  Affiliation Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Jonathan Rosenberg,

  Affiliation Division of Genitourinary Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Markus Riester,

  Affiliation Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Qishan Dai,

  Affiliation Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Sharron Lin,

  Affiliation Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Yanan Guo,

  Affiliation Division of Translational Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• W. Scott McDougal ,

  * E-mail: dk@rics.bwh.harvard.edu (DJK); WMCDOUGAL@PARTNERS.ORG (WSM)

  Affiliation Department of Urology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• David J. Kwiatkowski

  * E-mail: dk@rics.bwh.harvard.edu (DJK); WMCDOUGAL@PARTNERS.ORG (WSM)

  Affiliation Division of Translational Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯